⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VALN News
Valneva SE American Depositary Shares
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
businesswire.com
VALN
PFE
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
globenewswire.com
PFE
VALN
Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates
globenewswire.com
VALN
Valency Selected for DOE's Genesis Mission to Accelerate Nuclear Power Research with AI Agents
prnewswire.com
VALN
Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026
globenewswire.com
VALN
Valneva Announces Successful Outcome of its Annual General Meeting
globenewswire.com
VALN
Valneva Announces Availability of Documentation for its Annual General Meeting
globenewswire.com
VALN
Valneva to Participate at U.S. and European Investor Conferences in June
globenewswire.com
VALN
Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates
globenewswire.com
VALN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
accessnewswire.com
VALN